Navigation Links
Female High Waist Brief

ProductsFemale High Waist Brief
Company AART, Inc.
Item Female High Waist Brief
Features Inquire
Description Female High Waist Briefs
Info AART, Inc.
Customer Service: 866.853.6800
Web site: http://www.aartinc.net/index.html

Related medicine products :

1. Fertell Female Fertility Test
2. The Two-Piece Apron - Female
3. Self-Cath® Female
4. Self-Cath® Plus Straight Tip - Female
5. Personal Catheter-Female
6. Antibacterial Personal Catheter-Female
7. Hydrophilic Personal Catheter-Female
8. Antibacterial Hydro Personal Catheter-Female
9. 0-15 LPM Oxygen Flowmeter - 1/8" NPT Female Inlet
10. 0-3.5 LPM Oxygen Flowmeter - 1/8" NPT Female Inlet
11. Tube Style Oxygen Flowmeters - 1/8" NPT Female
Other Medicine News:Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 2Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 3Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 4Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 5Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 2Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 3Health News:Adult Type 2 Diabetes Can Be Predicted in Childhood 2Health News:Blue Cross and Blue Shield of Texas Announces Flexible, Affordable Blue MedicareRx(SM) Medicare Prescription Drug Plans 2Health News:New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves 2Health News:New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves 3Health News:Pa. Department of Public Welfare Reminds New Parents About 'Safe Haven' Law 2
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 1ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 2ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 3Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 1Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 1Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 3Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 4